Potential role of thymosin beta 4 in the treatment of nonalcoholic fatty liver disease

As a result of increased prevalence of obesity worldwide, non-alcoholic fatty liver disease (NAFLD) has become one of the most common causes of chronic liver disease. Although most NAFLD cases remain benign, some progress to end-stage liver diseases such as cirrhosis and hepatocellular carcinoma. Th...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Chronic Dis Transl Med
Egile Nagusiak: Jiang, Yong, Han, Tao, Zhang, Zhi-Guang, Li, Man, Qi, Feng-Xiang, Zhang, Ying, Ji, Ying-Lan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: KeAi Publishing 2017
Gaiak:
Perspective
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5643779/
https://ncbi.nlm.nih.gov/pubmed/29063072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cdtm.2017.06.003
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak